Karyoplasts obtained from full-grown oocytes of the starfish Aphelasterias japonica have practically no cytoplams and are incapable of maturation. Karyoplasts of oocytes of starfishes Marthasterias glacialis and Acanthaster planci have the cytoplasm (10%-15% of the total karyoplast volume) and are often capable of maturation, fertilization and one or several cleavage divisions. The embryoskaryoplasts completely lose supersensitivity and retain usual sensitivity to cytostatic antagonists of neurotransmitters. The assumption is made that the incapability or limited capability of this embryos for development might be due to a deficiency of certain components of the "prenervous" neurotransmitter systems.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-169X.1987.00205.xDOI Listing

Publication Analysis

Top Keywords

sensitivity cytostatic
8
embryos karyoplasts
4
karyoplasts starfish
4
starfish oocytes
4
oocytes development
4
development sensitivity
4
cytostatic neurotransmitter
4
neurotransmitter antagonists
4
antagonists karyoplasts/oocytes/sensitivity
4
karyoplasts/oocytes/sensitivity neurochemicals
4

Similar Publications

In Vitro Anticancer Effects of Aqueous Leaf Extract from L. ssp. .

Life (Basel)

November 2024

Department of Plant Physiology, Faculty of Biology, Sofia University "St. Kliment Ohridski", 8 Dragan Tsankov Blvd., 1164 Sofia, Bulgaria.

Despite significant efforts, cancer remains the second leading cause of mortality worldwide. The medicinal plant L. represents a valuable source of biologically active compounds with pharmacological activities including antioxidant, anti-inflammatory, antimicrobial, and antiviral.

View Article and Find Full Text PDF

Development and validation of the Normalized Organoid Growth Rate (NOGR) metric in brightfield imaging-based assays.

Commun Biol

December 2024

Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.

This study focuses on refining growth-rate-based drug response metrics for patient-derived tumor organoid screening using brightfield live-cell imaging. Traditional metrics like Normalized Growth Rate Inhibition (GR) and Normalized Drug Response (NDR) have been used to assess organoid responses to anticancer treatments but face limitations in accurately quantifying cytostatic and cytotoxic effects across varying growth rates. Here, we introduce the Normalized Organoid Growth Rate (NOGR) metric, specifically developed for brightfield imaging-based assays.

View Article and Find Full Text PDF
Article Synopsis
  • Glutamine is crucial for tumor growth, and its deprivation in solid tumors can hinder their growth and spread, particularly in human glioblastoma cell lines U87MG and T98G.
  • Research indicates that U87MG cells, which have a more differentiated phenotype, show increased glycolysis and stemness marker expression (CD133) when deprived of glutamine, while T98G cells shift towards oxidative phosphorylation and become less responsive to certain drugs.
  • The study highlights that metabolic and phenotypic differences between these glioblastoma cell lines lead to varying drug sensitivities, suggesting that treatment strategies should consider these differences for better outcomes.
View Article and Find Full Text PDF

The development of novel drug candidates is a current challenge in pharmacology where therapeutic benefits must exceed side effects. Toxicology testing is therefore a fundamental step in drug discovery research. Herein, we describe the first line of toxicology testing program, consisting in cell-based high-throughput screening assays, which have the advantage of being easy, rapid, cheap, and reproducible while providing quantitative information.

View Article and Find Full Text PDF

Nowadays, searching for novel antimicrobial agents is crucial due to the increasing number of resistant bacterial strains. Moreover, cancer therapy is a major challenge for modern medicine. Currently used cytostatics have a large number of side effects and insufficient therapeutic effects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!